The global digestives and intestinal remedies market size was valued at USD 17.52 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 3.5% from 2021 to 2028. The market is majorly driven by high demand for over-the-counter products, such as zientac and omez. There is an increase in cases of gastrointestinal disorders among people. Moreover, increasing cases of inflammatory bowel diseases, constipation, irritable bowel syndrome, and gastroesophageal reflux illnesses are expected to boost the market growth over the forecast period.
Digestive medicines are the most common over-the-counter medicines purchased by people. Moreover, physicians recommend the use of these medicines only after minor health issues, such as acidity and other digestive problems. However, in various countries, these medicines are sold directly to patients without prescription as per their rules and regulations.
Due to the Covid-19 pandemic, the sales of digestives and intestinal remedies were reduced globally. Lockdown measures to control the spread of COVID-19 and better hygiene have frozen the spread of seasonal illnesses, which has reduced the sales of over-the-counter medicines. Various pharmaceutical companies have displayed quarterly earnings reports, which showed a decrease in digestives and intestinal remedies, which has affected their bottom line sales of the market.
The digestive medicines accounted for the largest revenue share of over 50.0% in 2020 owing to the increasing demand for these drugs due to the rising health issues. The rising aging population is another key factor fueling the segment growth. Moreover, change in lifestyles and diets has increased the demand for digestive remedies. Hence, owing to these reasons, the segment is estimated to witness growth over the forecast period.
The remedies against gastrointestinal complaints segment will register the highest CAGR of 3.7% from 2021 to 2028 due to the growing cases of gastrointestinal diseases. Increasing healthcare expenditure and growth in the geriatric population are major factors boosting the segment growth. The growing burden of gastrointestinal disorders in various countries is also making the market more lucrative.
The offline segment dominated the market with a revenue share of over 70.0% in 2020. The demand for digestives and intestinal remedies is rising among customers due to more sustainability offered by these offline stores than any other channel. Hence, the segment is projected to observe growth during the forecast period.
The online segment is estimated to witness significant growth over the forecast period. Digestives and intestinal remedies can be purchased at a low price via online platforms. Such channels have the ability to provide various benefits such as coupon benefits and other offers. Moreover, the rising incidence of app-based sellers that are significantly popular is expected to drive the segment over the forecast period.
North America dominated the market and accounted for a revenue share of over 40.0% in 2020 due to the growing number of gastrointestinal diseases in this region. In addition, the growing geriatric and obese population in this region will drive the market over the forecast period. Increasing research and development activities, along with the presence of key market players, are boosting the market growth over the forecast period.
In Asia Pacific, the market is expected to register the fastest CAGR of 4.1% from 2021 to 2028. This can be credited to the increasing demand for digestives and intestinal remedies in this region. The rising prevalence of GI illnesses has led to the rising demand for digestives and intestinal remedies.
The main focus of the companies is on innovating new types of digestives and intestinal remedies to meet the increasing demand. Various new players are entering the market due to the low entry barriers. The increasing demand for digestives and intestinal remedies offers an opportunity for development in regions with high demand. Some prominent players in the global digestive and intestinal remedies market include:
|
Report Attribute |
Details |
|
Market size value in 2021 |
USD 17.99 billion |
|
Revenue forecast in 2028 |
USD 22.89 billion |
|
Growth Rate |
CAGR of 3.5% from 2021 to 2028 |
|
Base year for estimation |
2020 |
|
Historical data |
2017 - 2019 |
|
Forecast period |
2021 - 2028 |
|
Quantitative units |
Revenue in USD million/billion and CAGR from 2021 to 2028 |
|
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
|
Segments covered |
Type, distribution channel, region |
|
Regional scope |
North America; Europe; Asia Pacific; Central & South America; Middle East & Africa |
|
Country scope |
U.S.; Germany; U.K.; France; China; Japan; South Africa; Brazil |
|
Key companies profiled |
Bayer Healthcare; Johnson & Johnson; GlaxoSmithKline Plc; Procter & Gamble Co; Sanofi; Boehringer Ingelheim GmbH; Reckitt Benckiser; Group Plc (RB); Abbott Laboratories Inc.; Takeda Pharmaceutical Co. Ltd.; Menarini Group |
|
Customization scope |
Free report customization (equivalent up to 8 analysts’ working days) with purchase. Addition or alteration to country, regional & segment scope |
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2017 to 2028. For the purpose of this study, Million Insights has segmented the global digestives and intestinal remedies market report on the basis of type, distribution channel, and region:
Sign up today.
Call us at +1-408-610-2300 to speak with a
representative.
All Reports
